Celgene Reports Second Quarter 2019 Operating and Financial Results

Go back to Celgene Reports Second Quarter 2019 Operating and Financial Results

Celgene (CELG) Tops Q2 EPS by 23c, Raises Gudiance

July 30, 2019 7:35 AM EDT

Celgene (NASDAQ: CELG) reported Q2 EPS of $2.86, $0.23 better than the analyst estimate of $2.63. Revenue for the quarter came in at $4.4 billion versus the consensus estimate of $4.24 billion.

GUIDANCE:

Celgene sees FY2019 EPS of $10.65-$10.85. Celgene sees FY2019 revenue of $17.2-17.4... More